Nasdaq, Inc.
Nasdaq, Inc. (NDAQ) Financial Performance & Income Statement Overview
Analyze Nasdaq, Inc. (NDAQ) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Nasdaq, Inc. (NDAQ) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nasdaq, Inc. NDAQ financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.09B | $2.03B | $1.90B | $1.79B |
| Cost of Revenue | $357.00M | $1.22B | $1.17B | $786.00M |
| Gross Profit | $1.73B | $810.00M | $734.00M | $1.006B |
| Gross Profit Ratio | $0.83 | $0.40 | $0.39 | $0.56 |
| R&D Expenses | $432.00M | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $20.00M | $116.00M | $101.00M | $108.00M |
| Operating Expenses | $333.00M | $294.00M | $286.00M | $261.00M |
| Total Costs & Expenses | $690.00M | $1.51B | $1.42B | $1.31B |
| Interest Income | $11.00M | $8.00M | $8.00M | $6.00M |
| Interest Expense | -$96.00M | $97.00M | $98.00M | $99.00M |
| Depreciation & Amortization | $156.00M | $153.00M | $153.00M | $153.00M |
| EBITDA | $548.00M | $689.00M | $633.00M | $654.00M |
| EBITDA Ratio | $0.26 | $0.34 | $0.33 | $0.36 |
| Operating Income | $547.00M | $517.00M | $448.00M | $483.00M |
| Operating Income Ratio | $0.26 | $0.25 | $0.24 | $0.27 |
| Other Income/Expenses (Net) | -$59.00M | -$77.00M | -$92.00M | -$82.00M |
| Income Before Tax | $488.00M | $440.00M | $356.00M | $341.00M |
| Income Before Tax Ratio | $0.23 | $0.22 | $0.19 | $0.19 |
| Income Tax Expense | $93.00M | $85.00M | $51.00M | $119.00M |
| Net Income | $395.00M | $355.00M | $306.00M | $222.00M |
| Net Income Ratio | $0.19 | $0.17 | $0.16 | $0.12 |
| EPS | $0.69 | -$1.32 | $0.53 | $0.39 |
| Diluted EPS | $0.68 | -$1.31 | $0.53 | $0.38 |
| Weighted Avg Shares Outstanding | $575.12M | $575.12M | $575.12M | $576.38M |
| Weighted Avg Shares Outstanding (Diluted) | $579.19M | $579.02M | $579.02M | $578.95M |
Over the past four quarters, Nasdaq, Inc. demonstrated steady revenue growth, increasing from $1.79B in Q2 2024 to $2.09B in Q1 2025. Operating income reached $547.00M in Q1 2025, maintaining a consistent 26% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $548.00M, reflecting operational efficiency. Net income rose to $395.00M, with EPS at $0.69. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan